Thursday, April 6, 2017

IMPRIMIS PHARMACEUTICALS, INC. (NASDAQ:IMMY) Files An 8 ...

Market Exclusive-7 hours ago
Imprimis Pharmaceuticals, Inc. (Imprimis) is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates .
Post a Comment